Robotic mitral valve surgery in 2026: outcomes, adoption, the learning curve, and real-world evidence

PURPOSE OF REVIEW: Robotic mitral valve surgery has become an established minimally invasive approach for mitral valve repair. However, adoption remains concentrated within experienced, highly specialized, and high-volume centers. This review synthesizes contemporary evidence on clinical outcomes, utilization, expanding indications, learning curves, training, and cost, with emphasis on recent real-world evidence and barriers to broader implementation. RECENT FINDINGS: Large observational studies demonstrate comparable short-term and long-term outcomes after robotic mitral surgery relative to conventional approaches, with favorable postoperative recovery and durable repair. Robotic techniques are increasingly applied to complex degenerative disease, older patients, and concomitant cardiac procedures. Contemporary learning-curve data suggest that institutional experience, standardized workflows, mentorship, and experienced operative teams can substantially mitigate the learning curve within established programs. The 2026 Society of Thoracic Surgeons Expert Consensus Pathway provides the first standardized framework for robotic cardiac surgical training. SUMMARY: Robotic mitral surgery is supported by increasingly mature evidence demonstrating safety, durability, and favorable recovery. Future research should determine whether these outcomes can be reproduced across new programs through standardized training and proctoring, supported by prospective multicenter studies, patient-reported outcomes, and rigorous economic evaluation.